4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000145
Director sold 1,458 shares at $21.73 ($31,682)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cook Jennifer E. Director | 2024-06-06 | Sale 10b5-1 | −1,458 | $21.73 | $31,682 | 20,038 | D |
| Open-market sales · 1,458 sh · avg $21.73 · $31,682 | |||||||
Loading xslF345X05/wk-form4_1718064363.xml…